Avnet: "It's a really good stock. I'm glad you brought my attention. I cannot believe how low the P/E is. But then again, a lot of people feel that the move is about to end at any given moment, and that's what's wrong with Avnet."
Archer Aviation: "Let's pass on it. If we want to do a spec, there's better specs out there."
United Microelectronics: "This is a tough one. You know, it's not expensive, but it's up 135% [this year]. I just don't have a catalyst at these prices. I'm going to say no to it right now."
Altimmune: "I believe the GLPs are going to be able to address [fatty liver] better than anything else. But a $2 stock, count me in. But remember, stocks can go to zero."
Sign up now for the CNBC Investing Club to follow Jim Cramer's every move in the market.
Questions for Cramer?
Call Cramer: 1-800-743-CNBC
Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram
Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com